publication date: Sep. 20, 2019

Senate committee recommends $3 billion increase for NIH funding

By Alex Carolan

The Senate Committee on Appropriations Sept. 18 proposed a $3 billion raise for NIH in the 2020 fiscal year.

The amount proposed in the Senate version of the spending bill for the departments of Labor, HHS, Education, and other agencies is $1 billion above the level proposed in the bill that was passed by the House of Representatives June 19 (The Cancer Letter, Sept. 6).

The Senate bill would raise NIH funding  to $42.084 billion, 7.7% above the FY 2019 level.

The $3 billion increase, if it comes through, would mark a 40% increase since FY2016, the year that marks the end of a period of stagnation in NIH funding.

Under the Senate bill, NCI’s total budget would be $6.351 billion, over $200 million above the 2019 appropriated level. The total budget amount includes $195 million in Moonshot funds (The Cancer Letter, Sept. 6).

“With the House Appropriations Committee having already passed a bill earlier this year that includes a $2 billion increase for the NIH, the medical research advocacy community appreciates the fact that a $2 to $3 billion funding increase for the NIH in FY2020 is very much in sight,” Jon Retzlaff, chief policy officer of the American Association for Cancer Research, said to The Cancer Letter.

Increases to NIH’s budget enabled by bipartisan leadership in Congress allow “our nation’s basic researchers and physician-scientists to significantly accelerate the pace of progress against the hundreds of diseases that afflict millions of Americans,” Retzlaff said.

Retzlaff said much of the credit belongs to Sen. Roy Blunt … Continue reading Senate committee recommends $3 billion increase for NIH funding

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.